Concepedia

Stephanie Silveria

SS

Statistics

Publications

5

Citations

965

H-Index

5

Active since

2018

Affiliations

University of California, San Francisco(Current)

Stanford University

Parker Institute for Cancer Immunotherapy

Howard Hughes Medical Institute

University of California, Berkeley

Stephanie Silveria is an author at University of California, San Francisco specializing in immunology, life sciences, and immunoregulation.

ORCID

Publications per year

2018–2024

5

Publications

5

Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes

Jonathan T. Sockolosky, Eleonora Trotta, Giulia Parisi et al. · Science · 2018 · 373 citations · Full text

, , +17

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

David Wang, Jason Quiros, Kelly M. Mahuron et al. · Cell Reports · 2018 · 310 citations · Full text

, , +17

A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism

Eleonora Trotta, Paul Bessette, Stephanie Silveria et al. · Nature Medicine · 2018 · 196 citations

, , +13

Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy

Jamie B. Spangler, Eleonora Trotta, Jakub Tomala et al. · The Journal of Immunology · 2018 · 66 citations · Full text

, , +17

Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiation

Janneke G. C. Peeters, Stephanie Silveria, Merve Özdemir et al. · Cell Reports · 2024 · 20 citations · Full text

, , +17

1–5 of 5